We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Episodic and paroxysmal disorders
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Paediatric sleep-disordered breathing (SDB) refers to a condition in which a child experiences breathing interruptions during sleep. Symptoms of SDB can vary, ranging from frequent loud snoring to obstructive sleep apnoea (OSA). While OSA affects approximately two to four percent of children, its diagnosis is more commonly observed (up to 25 percent) in children with specific conditions such as obesity, sickle cell disease, and Down syndrome. SDB in children can lead to cardiovascular complications, but unlike adults, children are more prone to experiencing behavioural, learning and neurocognitive problems. Early diagnosis is crucial to prevent these potential complications.
Currently, the “gold standard” method for investigating SDB is an overnight cardio-respiratory sleep study (CRSS), which requires children to sleep in a laboratory setting while wires are attached to their face and body to record diagnostic measurements. This process is uncomfortable for the children, inconvenient for the family, and requires detailed manual analysis by a physiologist which is time-consuming and expensive. Consequently, there is a need for a solution that enables remote, automated diagnosis and monitoring of paediatric SDB in the familiar environment of the child's home.
The objective of this project is to develop a smartphone-based solution utilising unobtrusive sensors, which offers the prospect of low-cost and remote monitoring in the comfort of the child’s own home. 80 children with SDB will be recorded using both a home CRSS and the smart-phone solution. Signals from the two systems will be compared to evaluate the accuracy of the research method. Information will also be collected from the children and their parents to determine whether they find the smartphone system easy to use. This will help us to establish if the method can be used as a diagnostic tool for use in the home environment.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Validation of investigation /therapeutic procedures;
You can take part if:
You may not be able to take part if:
â—Ź Subjects whose parents/legal guardians/carers have special communication needs that cannot be met by the research study (hospital interpreters will be used where possible). â—Ź Known allergy to adhesive dressings. â—Ź Child anticipated to become distressed with additional sensors over and above the single oximetry sensor that was requested by the clinical team. â—Ź Clinical problem in the area in which the device will be attached, e.g. skin condition. â—Ź Children requiring an urgent home oximetry study, for whom delays due to the consenting and recruitment procedures may delay clinical management.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by SHEFFIELD CHILDREN'S NHS FOUNDATION TRUST and funded by Medical Research Council (MRC) .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 61639
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
